Long COVID in Inflammatory Bowel Diseases.
Crohn’s disease
SARS-CoV-2
biologics
ulcerative colitis
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
26 Nov 2021
26 Nov 2021
Historique:
received:
04
11
2021
revised:
23
11
2021
accepted:
26
11
2021
entrez:
10
12
2021
pubmed:
11
12
2021
medline:
11
12
2021
Statut:
epublish
Résumé
SARS-CoV-2-infected patients can experience long-lasting symptoms even after the resolution of the acute infection. This condition, defined as Long COVID, is now recognized as a public health priority and its negative impact on the quality of life of the patients could be more relevant in individuals with debilitating pathologies. We here evaluated the frequency of Long COVID in patients with inflammatory bowel diseases (IBD). IBD patients afferent for scheduled visits to our tertiary referral center at the Tor Vergata University Hospital, Rome, were recruited from 7 September to 22 October 2021. During the visits, patients were investigated about previous COVID-19 infection and the possible development of Long COVID. Fifty-three out of 528 IBD patients (10%) have had a SARS-CoV-2 infection. Of these, 21 patients (40%) developed Long COVID, and asthenia was the more frequent symptom as it occurred in nearly two-thirds of patients. Patients with Long COVID were more frequently females, while other clinical and demographic characteristics did not differ between patients with Long COVID and those without Long COVID. In particular, the IBD relapses occurred with the same frequency in the two groups. Long COVID appears to be common in IBD patients even though it does not influence the IBD course.
Sections du résumé
BACKGROUND AND AIMS
OBJECTIVE
SARS-CoV-2-infected patients can experience long-lasting symptoms even after the resolution of the acute infection. This condition, defined as Long COVID, is now recognized as a public health priority and its negative impact on the quality of life of the patients could be more relevant in individuals with debilitating pathologies. We here evaluated the frequency of Long COVID in patients with inflammatory bowel diseases (IBD).
METHODS
METHODS
IBD patients afferent for scheduled visits to our tertiary referral center at the Tor Vergata University Hospital, Rome, were recruited from 7 September to 22 October 2021. During the visits, patients were investigated about previous COVID-19 infection and the possible development of Long COVID.
RESULTS
RESULTS
Fifty-three out of 528 IBD patients (10%) have had a SARS-CoV-2 infection. Of these, 21 patients (40%) developed Long COVID, and asthenia was the more frequent symptom as it occurred in nearly two-thirds of patients. Patients with Long COVID were more frequently females, while other clinical and demographic characteristics did not differ between patients with Long COVID and those without Long COVID. In particular, the IBD relapses occurred with the same frequency in the two groups.
CONCLUSIONS
CONCLUSIONS
Long COVID appears to be common in IBD patients even though it does not influence the IBD course.
Identifiants
pubmed: 34884276
pii: jcm10235575
doi: 10.3390/jcm10235575
pmc: PMC8658587
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Curr Opin Pharmacol. 2011 Dec;11(6):640-5
pubmed: 22000933
J Med Econ. 2021 Jan-Dec;24(1):308-317
pubmed: 33555956
Aliment Pharmacol Ther. 2020 Jul;52(1):54-72
pubmed: 32348598
Inflamm Bowel Dis. 2021 Oct 27;:
pubmed: 34718595
Dig Liver Dis. 2020 Nov;52(11):1234-1235
pubmed: 32601036
J Pathol. 2004 Jun;203(2):631-7
pubmed: 15141377
J Infect. 2020 Dec;81(6):e4-e6
pubmed: 32853602
Nat Rev Microbiol. 2021 Mar;19(3):141-154
pubmed: 33024307
Nat Med. 2020 Dec;26(12):1829-1834
pubmed: 33020651
BMJ. 2021 Jul 26;374:n1648
pubmed: 34312178
Eur Rev Med Pharmacol Sci. 2021 Mar;25(5):2418-2424
pubmed: 33755981
Inflamm Bowel Dis. 2018 Mar 19;24(4):742-751
pubmed: 29562277
Science. 2005 Mar 25;307(5717):1920-5
pubmed: 15790845
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Clin Gastroenterol Hepatol. 2014 Sep;12(9):1443-51; quiz e88-9
pubmed: 24462626
J Clin Med. 2020 May 08;9(5):
pubmed: 32397198
Rev Clin Esp. 2020 Nov;220(8):480-494
pubmed: 33994573
J Crohns Colitis. 2020 Sep 16;14(9):1334-1336
pubmed: 32215548
Dig Liver Dis. 2020 Oct;52(10):1076-1079
pubmed: 32507692